Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
JP Stock MarketDetailed Quotes
4880 CellSource
- 828
- -15-1.78%
20min DelayNot Open Dec 20 15:30 JST
16.40BMarket Cap17.28P/E (Static)
883High828Low157.40KVolume851Open843Pre Close133.62MTurnover165052wk High1.77%Turnover Ratio19.81MShares82752wk Low41.66EPS TTM7.38BFloat Cap8160Historical High17.28P/E (Static)8.91MShs Float611Historical Low47.93EPS LYR6.52%Amplitude5.00Dividend TTM2.69P/B100Lot Size0.60%Div YieldTTM
CellSource Key Stats
Quarterly+Annual
YOY
| (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.12%1.05B | 10.76%1.17B | 5.54%4.51B | -21.16%1.1B | 5.06%1.24B | 26.82%1.11B | 29.07%1.06B | 46.25%4.27B | 71.26%1.4B | 54.50%1.18B |
| Cost of revenue | 12.98%393.07M | 46.29%409.71M | 9.59%1.33B | -6.23%350.73M | 3.60%346.83M | 33.24%347.91M | 16.90%280.07M | 42.60%1.21B | 54.34%374.03M | 50.28%334.79M |
| Gross profit | -13.38%661.08M | -2.01%763.81M | 3.94%3.19B | -26.60%753.69M | 5.65%888.68M | 24.10%763.17M | 34.08%779.46M | 47.75%3.06B | 78.38%1.03B | 56.25%841.18M |
| Operating expense | 28.64%585.47M | 30.31%557.95M | 31.49%1.96B | 45.85%575.4M | 28.40%504.81M | 23.47%455.12M | 27.07%428.18M | 38.06%1.49B | 50.64%394.52M | 39.35%393.16M |
| Staff costs | ---- | ---- | 23.66%649.3M | ---- | ---- | ---- | ---- | 42.92%525.08M | ---- | ---- |
| Selling and administrative expenses | ---- | ---- | 31.09%557.75M | ---- | ---- | ---- | ---- | 42.43%425.48M | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | 2.42%103.89M | ---- | ---- | ---- | ---- | 8.05%101.43M | ---- | ---- |
| -General and administrative expense | ---- | ---- | 40.06%453.86M | ---- | ---- | ---- | ---- | 58.19%324.05M | ---- | ---- |
| Research and development costs | ---- | ---- | -17.26%72.45M | ---- | ---- | ---- | ---- | 23.05%87.56M | ---- | ---- |
| Depreciation and amortization | ---- | ---- | 94.07%25.48M | ---- | ---- | ---- | ---- | 7.59%13.13M | ---- | ---- |
| -Depreciation | ---- | ---- | 94.07%25.48M | ---- | ---- | ---- | ---- | 7.59%13.13M | ---- | ---- |
| Rent and land expenses | ---- | ---- | 283.33%203.8M | ---- | ---- | ---- | ---- | 5.30%53.17M | ---- | ---- |
| Other operating expenses | ---- | ---- | 16.95%454.71M | ---- | ---- | ---- | ---- | 38.08%388.82M | ---- | ---- |
| Operating profit | -75.45%75.61M | -41.40%205.86M | -22.25%1.22B | -71.80%178.29M | -14.32%383.88M | 25.03%308.05M | 43.75%351.29M | 58.30%1.57B | 101.54%632.29M | 74.85%448.01M |
| Net non-operating interest income (expenses) | -5,085.71%-349K | -369K | -70,412.07%-40.9M | -85,116.67%-40.9M | 0 | 800.00%7K | 0 | 73.39%-58K | 52.94%-48K | 0 |
| Non-operating interest income | ---- | ---- | 85.71%13K | 0.00%6K | --0 | ---- | ---- | 250.00%7K | 500.00%6K | --0 |
| Non-operating interest expense | --351K | --369K | 3,345.45%379K | --379K | --0 | --0 | --0 | -91.91%11K | --0 | --0 |
| Total other finance cost | ---- | ---- | 74,957.41%40.53M | ---- | ---- | ---- | ---- | -35.71%54K | ---- | ---- |
| Net investment income | -120.64%-753K | 99.74%-45K | -140.71%-8.4M | -97.21%389K | 95.83%4.65M | -3.77%3.65M | -3,431.19%-17.09M | 3,249.77%20.63M | 1,279.92%13.95M | 6,152.63%2.38M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 335.41%29.93M | 74.35%-2.87M | 34.82M | -122.35%-12.71M | -453.33%-11.21M | 0 | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -36.22%2.07M | 39.02%7.29M | 10.6M | 115K | 1.99M | 3.25M | 5.24M | 0 | 0 | 0 |
| Less:Other special charges | 36.22%-2.07M | -39.02%-7.29M | ---10.6M | ---115K | ---1.99M | ---3.25M | ---5.24M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 1,595.06%106.98M | -114.78%-17K | 470.66%26.96M | 901.25%20.1M | 47.14%437K | 167.19%6.31M | 98.28%115K | -76.78%4.72M | -60.35%2.01M | 1,337.50%297K |
| Income before tax | -28.88%227.06M | -37.35%212.72M | -21.72%1.24B | -75.65%155.1M | -5.53%425.77M | 27.18%319.25M | 38.63%339.56M | 57.36%1.58B | 102.43%636.99M | 75.90%450.69M |
| Income tax | -43.32%70.98M | -44.28%68.82M | -44.05%316.54M | -144.60%-92.9M | -5.45%160.69M | 27.27%125.23M | 38.51%123.51M | 59.39%565.8M | 127.67%208.28M | 75.57%169.95M |
| Net income | -19.56%156.08M | -33.39%143.9M | -9.30%923.14M | -42.15%248M | -5.58%265.08M | 27.12%194.02M | 38.70%216.04M | 56.26%1.02B | 92.08%428.72M | 76.10%280.74M |
| Net income continuous operations | -19.56%156.08M | -33.39%143.9M | -9.30%923.14M | -42.15%248M | -5.58%265.08M | 27.12%194.02M | 38.70%216.04M | 56.26%1.02B | 92.08%428.72M | 76.10%280.74M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -19.56%156.08M | -33.39%143.9M | -9.30%923.14M | -42.15%248M | -5.58%265.08M | 27.12%194.02M | 38.70%216.04M | 56.26%1.02B | 92.08%428.72M | 76.10%280.74M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.56%156.08M | -33.39%143.9M | -9.30%923.14M | -42.15%248M | -5.58%265.08M | 27.12%194.02M | 38.70%216.04M | 56.26%1.02B | 92.08%428.72M | 76.10%280.74M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -24.08%7.88 | -37.11%7.27 | -10.38%48.88 | -43.86%12.89 | -6.58%14.05 | 26.89%10.38 | 38.28%11.56 | 55.08%54.54 | 90.86%22.96 | 75.09%15.04 |
| Diluted earnings per share | -22.38%7.84 | -35.68%7.23 | -9.53%47.93 | -42.67%12.79 | -5.61%13.8 | 27.20%10.1 | 38.59%11.24 | 56.24%52.98 | 92.16%22.31 | 76.14%14.62 |
| Dividend per share | 0 | 0 | 5 | 5 | ||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |